GSK Annual Report 2002
GSK Annual Report 2002
GSK Annual Report 2002
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Financial record GlaxoSmithKline 145<br />
Pharmaceutical sales – USA Q4 <strong>2002</strong> Q3 <strong>2002</strong> Q2 <strong>2002</strong> Q1 <strong>2002</strong><br />
£m CER % £m CER % £m CER % £m CER %<br />
CNS 900 19 834 27 859 27 712 13<br />
Depression 628 21 583 36 590 37 474 10<br />
Seroxat/Paxil 386 10 347 27 387 39 293 (3)<br />
Wellbutrin 242 42 236 53 203 35 181 41<br />
Migraine 176 12 164 6 175 7 155 20<br />
Imigran/Imitrex 163 13 153 8 159 7 141 21<br />
Naramig/Amerge 13 (5) 11 (16) 16 12 14 20<br />
Lamictal 67 39 61 41 64 44 55 55<br />
Requip 14 >100 11 (10) 13 43 9 15<br />
Zyban 11 (4) 12 (3) 11 (17) 13 (15)<br />
Respiratory 529 28 475 19 531 24 488 46<br />
Seretide/Advair,<br />
Flixotide/Flovent, Serevent 425 43 366 24 394 29 372 60<br />
Seretide/Advair 251 71 210 >100 224 >100 191 >100<br />
Flixotide/Flovent 101 25 90 (20) 95 (30) 101 (18)<br />
Serevent 73 5 66 (27) 75 (25) 80 (26)<br />
Flixonase/Flonase 92 1 103 19 119 24 99 16<br />
Ventolin 3 (62) (2) – 1 (91) 6 (21)<br />
Becotide – – – – – – – –<br />
Anti-virals 326 12 299 16 294 19 294 28<br />
HIV 227 8 215 14 210 8 205 21<br />
Combivir 88 (1) 82 (2) 84 (3) 84 (1)<br />
Trizivir 53 29 50 69 52 >100 45 >100<br />
Epivir 45 8 41 8 39 (4) 39 11<br />
Retrovir 6 (7) 6 (5) 5 (9) 6 20<br />
Ziagen 27 13 28 24 22 (14) 24 8<br />
Agenerase 8 (4) 8 (14) 8 (25) 7 (18)<br />
Herpes 86 18 72 21 74 24 77 46<br />
Valtrex 79 34 65 29 68 34 63 44<br />
Zovirax 7 (48) 7 (22) 6 (28) 14 56<br />
Zeffix 3 53 3 72 3 57 3 >100<br />
Anti-bacterials 232 (34) 155 (34) 262 (3) 326 (17)<br />
Augmentin 163 (41) 88 (40) 196 18 257 (7)<br />
Zinnat/Ceftin 9 (77) 5 (79) 7 (87) 13 (77)<br />
Fortum 10 6 9 (23) 9 3 9 (3)<br />
Amoxil 9 >100 8 4 8 63 7 (56)<br />
Metabolic and gastro-intestinal 229 >100 148 (30) 215 (2) 192 19<br />
Avandia 198 >100 130 (32) 193 (1) 167 21<br />
Zantac 23 (29) 17 (15) 21 (14) 25 (1)<br />
Vaccines 65 1 73 16 70 14 82 35<br />
Hepatitis 55 15 53 23 48 9 55 24<br />
Infanrix 10 (36) 19 (4) 23 40 27 72<br />
Oncology and emesis 208 49 173 14 185 13 174 33<br />
Zofran 154 51 125 22 130 15 116 24<br />
Hycamtin 15 >100 12 (36) 19 4 17 24<br />
Cardiovascular 112 (1) 115 30 110 25 93 17<br />
Coreg 73 (4) 90 66 75 37 57 21<br />
Arthritis (Relafen) 1 (91) 2 (92) 2 (96) 3 (93)<br />
Other (10) >(100) 5 80 23 (15) 11 >100<br />
Total pharmaceutical sales 2,592 14 2,279 9 2,551 15 2,375 15
Change language